167 related articles for article (PubMed ID: 8932340)
1. Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.
Papp J; Csokay B; Bosze P; Zalay Z; Toth J; Ponder B; Olah E
Br J Cancer; 1996 Nov; 74(10):1592-7. PubMed ID: 8932340
[TBL] [Abstract][Full Text] [Related]
2. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.
Eccles DM; Russell SE; Haites NE; Atkinson R; Bell DW; Gruber L; Hickey I; Kelly K; Kitchener H; Leonard R
Oncogene; 1992 Oct; 7(10):2069-72. PubMed ID: 1408149
[TBL] [Abstract][Full Text] [Related]
3. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.
Niederacher D; Picard F; van Roeyen C; An HX; Bender HG; Beckmann MW
Genes Chromosomes Cancer; 1997 Mar; 18(3):181-92. PubMed ID: 9071571
[TBL] [Abstract][Full Text] [Related]
4. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation.
Garcia A; Bussaglia E; Machin P; Matias-Guiu X; Prat J
Int J Gynecol Pathol; 2000 Apr; 19(2):152-7. PubMed ID: 10782412
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.
Eccles DM; Brett L; Lessells A; Gruber L; Lane D; Steel CM; Leonard RC
Br J Cancer; 1992 Jan; 65(1):40-4. PubMed ID: 1310251
[TBL] [Abstract][Full Text] [Related]
9. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.
Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ
Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450
[TBL] [Abstract][Full Text] [Related]
10. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma.
Foulkes WD; Black DM; Stamp GW; Solomon E; Trowsdale J
Int J Cancer; 1993 May; 54(2):220-5. PubMed ID: 8098014
[TBL] [Abstract][Full Text] [Related]
11. Comparison of alterations of chromosome 17 in carcinoma of the ovary and of the breast.
Caduff RF; Svoboda-Newman SM; Ferguson AW; Frank TS
Virchows Arch; 1999 Jun; 434(6):517-22. PubMed ID: 10394886
[TBL] [Abstract][Full Text] [Related]
12. Whole chromosome 17 loss in ovarian cancer.
Tavassoli M; Ruhrberg C; Beaumont V; Reynolds K; Kirkham N; Collins WP; Farzaneh F
Genes Chromosomes Cancer; 1993 Nov; 8(3):195-8. PubMed ID: 7509629
[TBL] [Abstract][Full Text] [Related]
13. Human epithelial ovarian cancer allelotype.
Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB
Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726
[TBL] [Abstract][Full Text] [Related]
14. Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types.
Okada S; Tsuda H; Takarabe T; Yoshikawa H; Taketani Y; Hirohashi S
Jpn J Cancer Res; 2002 Jul; 93(7):798-806. PubMed ID: 12149146
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors.
Pieretti M; Powell DE; Gallion HH; Case EA; Conway PS; Turker MS
Hum Pathol; 1995 Apr; 26(4):393-7. PubMed ID: 7705817
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.
Tavassoli M; Steingrimsdottir H; Pierce E; Jiang X; Alagoz M; Farzaneh F; Campbell IG
Br J Cancer; 1996 Jul; 74(1):115-9. PubMed ID: 8679443
[TBL] [Abstract][Full Text] [Related]
18. [Amplification of the erbb-2 (Her-2/NEU), erbb-1 (HER-1) and c-myc oncogenes is often combined with the deletion of the short arm of chromosome 17 in human carcinoma].
Imianitov EN; Chernitsa OI; Nikiforova IF; Serova OM; Sokolov SI; Laur OIu; Togo AV; Kniazev PG
Mol Biol (Mosk); 1993; 27(4):888-94. PubMed ID: 8103188
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors.
Wertheim I; Tangir J; Muto MG; Welch WR; Berkowitz RS; Chen WY; Mok SC
Oncogene; 1996 May; 12(10):2147-53. PubMed ID: 8668340
[TBL] [Abstract][Full Text] [Related]
20. Allele losses on chromosome 17 in human epithelial ovarian carcinoma.
Eccles DM; Cranston G; Steel CM; Nakamura Y; Leonard RC
Oncogene; 1990 Oct; 5(10):1599-601. PubMed ID: 2250917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
